Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with ... Novartis and Nycomed. The authors have no other relevant affiliations or financial involvement ...

Ipratropium bromide 0.5 mg/3 mL (0.017%), albuterol (as sulfate) 2.5 mg/3 mL (0.083%); soln for inh. Not for primary treatment of acute attack. Avoid excessive use. Discontinue if paradoxical ...

To determine whether longer treatment with ipratropium bromide might aid recovery a study was undertaken in 106 patients with acute asthma. METHODS A double blind, randomised, placebo controlled, ...

Several single-dose studies demonstrated that, in asthmatic patients, acute bronchodilation induced by ipratropium bromide was significantly lower than acute bronchodilation induced by salbutamol ...

Ipratropium is used in the treatment of chronic obstructive pulmonary disease and asthma. Brand Names: Ipravent, Ipneb, ...

Clinically, she is well but parents would like to know whether inhalers will help. We searched PubMed and Cochrane databases using the terms ‘wheeze’ AND ‘bronchodilator’ OR ‘β-agonist’ ...

Not currently distributed in Australia. Each 1 mL of Atrovent Adult UDV contains 522 micrograms of ipratropium bromide monohydrate (equivalent to 500 micrograms of ipratropium bromide) as the ...

Atrovent Inhalation Solution contains the active ingredient ipratropium bromide monohydrate. It belongs to a group of medicines called anticholinergic bronchodilators. Atrovent Inhalation Solution ...